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Ghrelin, a peptide hormone, newly identiﬁed in oral mucosal tissues, has emerged recently as an important mediator of the
processesofmucosaldefense.Here,wereportonthemechanismofghrelinprotectionagainstethanolcytotoxicityinratsublingual
salivaryglandcells.TheprotectiveeﬀectofghrelinwasassociatedwiththeincreaseinNOandPGE2,andupregulationincytosolic
phospholipase A2 (cPLA2) activity and arachidonic acid (AA) release. The loss in countering eﬀect of ghrelin occurred with
cNOS inhibitor, L-NAME, as well as indomethacin and COX-1 inhibitor, SC-560, while COX-2 inhibitor, NS-398, and iNOS
inhibitor, 1400W, had no eﬀect. The eﬀect of L-NAME was reﬂected in the inhibition of ghrelin-induced cell capacity for NO
production, cPLA2 activation and PGE2 generation, whereas indomethacin caused only the inhibition in PGE2. Moreover, the
ghrelin-inducedup-regulationinAAreleasewasreﬂectedinthecPLA2 phosphorylationandS-nitrosylation.Inhibitioninghrelin-
induced S-nitrosylation was attained with L-NAME, whereas the ERK inhibitor, PD98059, caused the blockage in cPLA2 protein
phosphorylation as well as S-nitrosylation. Thus, ghrelin protection of salivary gland cells against ethanol involves cNOS-derived
NO induction of cPLA2 activation through S-nitrosylation for the increase in AA release at the site of COX-1 action for PGE2
synthesis.
1.Introduction
Alcohol abuse is a well-recognized cause of damage to
the liver, brain and gastrointestinal tract, and its excessive
consumption is associated with an increased risk of cancer
of the liver, pharynx, larynx, esophagus, and the oral cavity
[1–3]. Moreover, alcoholics and animals exposed to ethanol
exhibit diminished secretion of saliva, and often develop
inﬂammation of oral mucosa [3, 4]. The salivary gland
acinar cell responses to ethanol cytotoxicity are manifested
by the elevation in proinﬂammatory cytokine production,
enhancement in apoptosis, disturbances in nitric oxide (NO)
signaling pathways, and the impairment in prostaglandin
generation [5–7]. The disturbances in salivary gland acinar
cells by ethanol also aﬀect the production of salivary mucins,
the glycoproteins that play major role in the preservation of
oral mucosal integrity [8, 9].
Although the maintenance of mucosal integrity along
the alimentary tract relays on multiple molecular processes,
the two of the most prominent are the production of
NO by the nitric oxide synthase (NOS) system and the
formationofprostaglandinsgeneratedfromAAbytheaction
of cyclooxygenase (COX) enzymes [10–14]. Furthermore,
the literature data support the existence of a functional
relationship between the products of NOS and COX sys-
tems, and there are strong indications that the enzyme
compartmentalization and substrate availability determines
the segregated utilization of the respective products in phys-
iological and pathophysiological processes [15–17]. Indeed,
the stimulation of NO production through NOS induction2 Advances in Pharmacological Sciences
or the exogenous NO donors leads to up-regulation in COX
enzymes activation and the increase prostaglandin, while
the inhibition of NOS decreases prostaglandin formation
[16–20]. Moreover, the NO-induced COX-2 activation has
been linked to the enzyme protein S-nitrosylation [17].
Studies indicate that the critical event responsible for
rapid changes in prostaglandin production is the release of
AA from membrane phospholipids by the action of cytosolic
phospholipase A2 (cPLA2)e n z y m e[ 21–23]. The cleavage of
AA from sn-2 position of membrane glycerophospholipids
by the action of highly selective Group IV cPLA2 is the
initial and rate limiting event in prostaglandin production,
as well as a key step in the generation of other potent lipid
messengers,suchasleukotrienesandPAF[22,24].Theactiv-
ity of cPLA2 is tightly regulated by posttranslational mech-
anism involving MAPK/ERK-dependent enzyme protein
phosphorylation that facilitates the enzyme translocation
from cytosol to membrane to gain access to phospholipid
substrates [14, 25–27]. Moreover, it has been reported that
the NO-induced enzyme protein S-nitrosylation results in
cPLA2 activation and up-regulation in arachidonic acid
release for prostaglandin synthesis [28].
Advances in understanding the nature of factors involved
inthemaintenanceofmucosalintegrityalongthealimentary
tract have brought to the forefront the role of ghrelin in
the process of mucosal defense and repair [29–32]. This
28-amino acid peptide hormone, produced mainly in the
stomach [29], but also identiﬁed recently in oral mucosa,
saliva, and the acinar cells of salivary glands [33], has
been recognized as an important regulator of the NOS
and COX systems, and implicated in the control of local
inﬂammations, healing of experimentally induced gastric
ulcers, and the protection of gastric mucosa against acute
damage induced by ethanol [30–32, 34, 35].
In this study, we investigated the mechanism of ghrelin
protection against ethanol cytotoxicity in the acinar cells of
ratsublingualsalivarygland.Theresultsofourﬁndingsshow
that ghrelin modulation of ethanol cytotoxicity involves
cNOS-derived NO induction of cPLA2 activation through S-
nitrosylation for the increase in AA release for prostaglandin
synthesis.
2.MaterialandMethods
2.1. Sublingual Gland Cell Preparation. The acinar cells
of sublingual salivary gland were collected from freshly
dissected rat salivary glands [14]. The minced tissue was
s u s p e n d e di nﬁ v ev o l u m e so fi c e - c o l dD u l b e c c o ’ sm o d i ﬁ e d
(Gibco) Eagle’s minimal essential medium (DMEM), sup-
plemented with fungizone (50μg/ml), penicillin (50U/ml),
streptomycin (50μg/ml), and 10% fetal calf serum, and
gently dispersed by trituration with a syringe, and set-
tled by centrifugation. Following three consecutive rinses
with DMEM, the cells were resuspended in the medium
to a concentration of 2 × 107 cell/ml. The viability of
cell preparations before and during the experimentation,
assessed by Trypan blue dye exclusion assay, was greater than
98%.
2.2.Ethanol-InducedCytotoxicity. Aliquotsofcellsuspension
(1 ml) were transferred to DMEM in culture dishes and
incubated for 2 hours at 37◦C under 95% O2/5% CO2 atmo-
sphere in the absence and the presence of 3% of ethanol. In
the experiments evaluating the eﬀect of ghrelin (rat, Sigma),
indomethacin, COX-1 inhibitor, SC-560, COx-2 inhibitor,
NS-398 (Sigma), cNOS inhibitor, L-NAME and its inactive
isomer, D-NAME, iNOS inhibitor, 1400W and ERK1/2
inhibitor PD98059 (Calbiochem), and ascorbate (Sigma),
the cells were ﬁrst treated for 30min with the indicated
dose of the agent or vehicle followed by 2h incubation with
ethanol [14]. At the conclusion of incubation, the aliquots of
cell suspension from the control and various experimental
conditions were centrifuged at 300 × g for 5min and the
supernatants used for the measurement of cytotoxicity using
TOX-7lactatedehydrogenaseassaykitinaccordancewiththe
manufacturer’s (Sigma) instructions.
2.3. PGE2 and NO Quantiﬁcation. The aliquots of the acinar
cell suspension from the control and various experimental
conditions were centrifuged at 1500 × gf o r5m i na n d
the conditioned medium supernatant collected. PGE2 assays
were carried out using a PGE2 EIA kit (Cayman) and 100μl
aliquots of the spent medium supernatant, according to the
manufacturer’s instruction. To assess NO production in the
acinar cells, we measured the stable NO metabolite, nitrite,
accumulation in the culture medium using Griess reaction
[36].
2.4.AAReleaseandcPLA2 ActivityAssay. Toassesstherelease
of AA from the acinar cells of salivary gland into the incu-
bation medium, aliquots of the cell suspension (1ml) were
labeled in DMEM with 20μCi of [5,6,8,9,11,12,14,15-
3H]arachidonic acid for 4 h [27], and resuspended in fresh
DMEM free of albumin. The cells were then treated with
the indicated dose of the agent of interest or vehicle and
incubated for 2h in the presence of 3% ethanol, and fol-
lowing centrifugation the supernatant was analyzed for the
released [3H]arachidonic acid by scintillation spectrometry.
The measurement of cPLA2 activity in the acinar cells
following various experimental conditions was carried out
using cPLA2 assay kit (Cayman) with thioarachidonoylphos-
phatidylcholine as substrate [27].
2.5. cPLA2 S-nitrosylation Assay. Detection of cPLA2 S-
nitrosylation was carried out utilizing a biotin switch
procedure for protein S-nitrosylation [37, 38]. The acinar
cells were treated with ghrelin (0.7μg/ml) or L-NAME
(400μM) + ghrelin or PD98059 (30μM) + ghrelin and
incubated for 2h in the presence of 3% ethanol. Following
centrifugation, the recovered cells were lysed in HEN lysis
buﬀer and the unnitrosylated thiol groups were blocked with
S-methyl methanethiosulfonate reagent [38]. The proteins
were precipitated with acetone, resuspended in HEN buﬀer
containing 1% SDS, and subjected to targeted nitrothiol
group reduction with sodium ascorbate (100mM). The free
thiols were then labeled with biotin and the biotinylated
proteins were recovered on streptavidin beads. The formedAdvances in Pharmacological Sciences 3
0
20
40
60
80
100
C
e
l
l
v
i
a
b
i
l
i
t
y
(
%
)
∗
0.1 0.2 0.5 0.7 1 Control Et (3%)
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
Gh (µg/mL) + Et (3%)
(a)
0
50
100
150
200
250
0
5
10
15
20
25
NO
PGE2
N
i
t
r
i
t
e
(
µ
M
/
m
L
)
P
G
E
2
(
p
g
/
m
L
)
0.2 0.5 0.7 1 Control Et (3%)
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
Gh (µg/mL) + Et (3%)
(b)
Figure 1: Eﬀect of ghrelin on ethanol-induced cytotoxicity (a) and changes in the production of nitrite and PGE2 (b) in rat sublingual
salivary gland acinar cells. The cells, preincubated with the indicated concentrations of ghrelin (Gh), were incubated for 2h in the presence
of 3% ethanol (Et). Values represent the means ± SD of ﬁve experiments.
∗P <. 05 compared with that of control.
∗∗P <. 05 compared with
that of Et alone.
streptavidin bead-protein complex was washed with neu-
tralization buﬀer, and the bound proteins were dissociated
from streptavidin beads with 50μlo fe l u t i o nb u ﬀer (20mM
HEPES, 100mM NaCl, 1mM EDTA, pH 7.7) containing 1%
2-mercaptoethanol [37]. The obtained proteins were then
analyzed by Western blotting.
2.6. Western Blot Analysis. The acinar cells from the con-
trol and experimental treatments were collected by cen-
trifugation, washed with phosphate-buﬀered saline and
resuspended in ice-cold lysis buﬀer [14]. Following brief
sonication, the cell lysates were centrifuged at 12,000g for
10min, and the supernatants were subjected to protein
determination using BCA protein assay kit (Pierce). The
samples, including those from biotin switch procedure,
were then resuspended in loading buﬀer, boiled for 5
min, and subjected to SDS-PAGE using 50μg protein/lane
[27]. The separated proteins were transferred onto nitro-
cellulose membranes, blocked with 5% skim milk, and
incubated with the antibody against the phosphorylated
cPLA2 protein at 4◦C for 16h. After 1h incubation with the
horseradish peroxidase-conjugated secondary antibody, the
phosphorylated proteins were revealed using an enhanced
chemiluminescence detection kit (Pierce). Membranes were
stripped by incubation in 1M Tris-HCl (pH 6.8), 10%
SDS, and 10mM dithiotreitol for 30 min at 55◦C, and
reprobed with antibody against total cPLA2. Immunoblot-
ting was performed using speciﬁc antibodies directed
against cPLA2 and phospho-cPLA2 (Ser505)( C e l lS i g n a l -
ing).
2.7. Data Analysis. All experiments were carried out using
duplicate sampling and the results are expressed as means
± SD. Analysis of variance (ANOVA) followed by nonpara-
metricKruskal-Wallistestwasusedtodeterminesigniﬁcance
and the signiﬁcance level was set at P<. 05.
3. Results
To examine the role of salivary ghrelin in oral mucosal
protection against ethanol cytotoxicity, we employed pri-
mary culture of rat sublingual salivary gland acinar cells
exposed to incubation with ethanol in conjunction with
lactate dehydrogenase assay [14]. Using ethanol at the dose
range (3%) that impairs the cell capacity for mucin synthesis
and prostaglandin generation [5, 9], we determined that
preincubation of the acinar cells with ghrelin led to a
concentration-dependent prevention of ethanol cytotoxicity,
a n dr e s u l t e dn e a r l yc o m p l e t ep r o t e c t i o na t0 . 7 μg/ml of
ghrelin (Figure 1(a)). Moreover, we found that cytotoxicity
induced in sublingual salivary gland acinar cells by 3%
ethanol was reﬂected in a 54.5% drop in NO production
and a 24.7% reduction in PGE2 generation (Figure 1(b)),
and that ghrelin at the concentration of 0.7μg/ml for
the protection against ethanol cytotoxicity evoked a 38.3%
increase in the mucosal cell PGE2 generation and a 2.3-fold
increase in NO production (Figure 1(b)).
Our results furthermore revealed that a concentration-
dependent loss in the protective eﬀect of ghrelin on the
ethanol-induced salivary gland acinar cell toxicity was
attained with cNOS inhibitor, L-NAME (Figure 2(a))a s
well as cyclooxygenase (COX-1 and COX-2) inhibitor,
indomethacin, and a speciﬁc COX-1 inhibitor, SC-560
(Figure 2(b)), while selective iNOS inhibitor, 1400W and a
speciﬁc COX-2 inhibitor, NS-398 had no eﬀect (Figure 2).
Moreover, while the eﬀect of L-NAME was reﬂected in
the inhibition of ghrelin-induced acinar cell capacity for
NO production as well as PGE2 generation (Figure 3(a)),
the pretreatment with indomethacin and COX-1 inhibitor,
SC-560, led only to the inhibition in ghrelin-induced PGE2
generation (Figure 3(b)). The stimulatory eﬀect of ghrelin
on the acinar cell capacity for NO and PGE2 production,
however, was not aﬀected by the inclusion of iNOS inhibitor
1400W and COX-2 inhibitor, NS-398. These results indicate
that ghrelin-induced up-regulation in NO production and4 Advances in Pharmacological Sciences
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Figure 2: Eﬀect of nitric oxide synthase (a) and cyclooxygenase (b) inhibitors on the ghrelin (Gh)-induced protection of sublingual salivary
gland acinar cells against ethanol (Et) cytotoxicity. The cells, preincubated with the indicated concentrations of L-NAME (LN), 200 μM
D-NAME (DN) and 30μM 1400W (14W) or indomethacin (In), SC-560 (SC) and NS-398 (NS), were treated with Gh at 0.7μg/ml and
incubated for 2h in the presence of 3% Et. The cell-free aliquots of the medium were assayed for lactate dehydrogenase release. Values
represent the means ± SD of ﬁve experiments.
∗P <. 05 compared with that of control.
∗∗P <. 05 compared with that of Et alone.
∗∗∗P <. 05 compared with that of Gh + Et.
PGE2 generation occurs with the involvement of respective
cNOS and COX-1 enzymes, and suggest the participation
of cNOS in sublingual salivary gland acinar cell processes of
PGE2 generation in response to ghrelin.
Further,wefoundthatthecountering eﬀectofghrelinon
the ethanol-induced changes in the acinar cell production of
NO and PGE2 was subject to suppression by PP2, a selective
inhibitor of tyrosine kinase Src (Figure 3(a)). We also
revealed that the eﬀect of ghrelin on the acinar cell capac-
ity for PGE2 generation was inhibited by MAPK/ERK1/2
inhibitor,PD98059,whereastheproductionofNOremained
unaﬀected (Figure 3(a)). These results, thus, implicate the
activationoftyrosinekinaseSrcasatriggeringeventwhereby
ghrelin is capable of aﬀecting the acinar cell capacity for NO
as well as PGE2 generation. The ﬁndings also point to the
role of MAPK/ERK in the processes of PGE2 generation.
We next sought additional leads into the involvement of
cNOS in ghrelin-induced signaling leading to up-regulation
in salivary gland cell PGE2 generation. As the initial and rate
limiting step in prostaglandin production is the liberation of
arachidonic acid from membrane phospholipids by highly
selective cPLA2 [22–24], we employed the acinar cells labeled
with [3H]arachidonic acid to assess the eﬀect of ghrelin
on arachidonic release in the presence of nitric oxide
synthase inhibition. As shown in Figure 4(a), the ethanol-
induced cytotoxicity was reﬂected in a 20.4% decrease in
the acinar cell arachidonic acid release, while preincubation
with ghrelin, at its optimal concentration (0.7μg/ml) for
the suppression of the cytotoxic eﬀect of ethanol, resulted
in a 28.3% stimulation in arachidonic acid release. This
eﬀect of ghrelin on was subject to inhibition by the cNOS
inhibitor, L-NAME, while the iNOS inhibitor, 1400W had
no eﬀect. Moreover, the ghrelin-induced up-regulation in
the acinar cell arachidonic acid release was inhibited by
Src kinase inhibitor, PP2 and MAPK/ERK1/2 inhibitor,
PD98059 (Figure 4(a)) The stimulatory eﬀect of ghrelin on
the arachidonic acid release, however, was not aﬀected by the
inclusion of indomethacin or selective COX-1 and COX-2
inhibitors, SC-560 and NS-398 (Figure 4(b)).
As the activation of cPLA2 for rapid release of arachi-
donic acid involves Src kinase-dependent MAPK/ERK acti-
vation of the enzyme through phosphorylation [14, 25,
27], we further measured the acinar cell cPLA2 enzymatic
activity. We found that preincubation with ghrelin coun-
tered the detrimental eﬀect of ethanol on arachidonic acid
release and evoked a 71.8% increase in the cPLA2 activity
(Figure 4). The ghrelin-induced up-regulation in cPLA2
activity, furthermore, was subject to suppression by Src
inhibitor, PP2 and ERK1/2 inhibitor, PD98059 as well as
to the inhibitor of cNOS, L-NAME (Figure 4(a)), whereas
pretreatment with indomethacin or selective COX-1 and
COX-2 inhibitors did not cause any discernible alteration
in the enzyme activity (Figure 4(b)). These results, together
with the inhibitory eﬀect of PP2 on the ghrelin-induced
increase in NO production (Figure 3(a)), point to the Src
kinase as an upstream eﬀector of cNOS in the observed
up-regulation in cPLA2 activation for the increase in PGE2
generation.
Recent literature data indicate that up-regulation in NO
production exerts the modulatory eﬀect on PGE2 synthesis
through protein cysteine S-nitrosylation of cyclooxygenase
and cPLA2 enzymes [17, 20, 28]. As the S-nitrosylated
proteins show susceptibility to ascorbic acid [17, 37, 38],
we analyzed the eﬀect of this agent on the ghrelin-induced
changes in the acinar cell capacity for PGE2 generation.
The results revealed that preincubation of the acinar cells
with ascorbate caused not only the decrease in the ghrelin-
induced cell capacity for PGE2 production (Figure 3(b)), but
also elicited suppression in the ghrelin-induced arachidonic
acid release and the activity of cPLA2(Figure 4(b)). To
assess further the role of S-nitrosylation in the course of
events leading to cPLA2 activation by ghrelin, the acinarAdvances in Pharmacological Sciences 5
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Figure 3: Eﬀect of nitric oxide synthase (a) and cyclooxygenase (b)
inhibitors on the ghrelin (Gh)-induced changes in the production
of PGE2 and nitrite by sublingual salivary gland acinar cells in the
presence of ethanol (Et). The cells, preincubated with 400μML -
NAME (LN), 30μM1400W(14W),20μMPP2and30μMPD98059
(PD) or 2μM indomethacin (In), 15μM SC-560 (SC), 20μM NS-
398 (NS) and 300μM ascorbate (As), were treated with 0.7μg/ml
Gh and incubated for 2h in the presence of 3% Et. Values represent
the means ± SD of ﬁve experiments.
∗P <. 05 compared with that
of control.
∗∗P <. 05 compared with that of Et alone.
∗∗∗P <. 05
compared with that of Gh + Et.
cells prior to ghrelin incubation, were pretreated with
cNOS inhibitor, L-NAME or ERK1/2 inhibitor, PD98059,
and the lysates subjected to biotin switch procedure were
examined with antibodies directed against phospho-cPLA2
and total cPLA2. We observed that ghrelin prevention of the
ethanol-induced cytotoxicity was reﬂected in the increase
in cPLA2 protein phosphorylation as well as S-nitrosylation
(Figure 5). Preincubation with L-NAME resulted in the
0
100
200
300
400
0
0.3
0.6
0.9
1.2
1.5
C
o
n
t
r
o
l
E
t
(
3
%
)
G
h
+
E
t
L
N
+
G
h
+
E
t
1
4
W
+
G
h
+
E
t
P
P
2
+
G
h
+
E
t
P
D
+
G
h
+
E
t
∗
∗
AA
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
c
P
L
A
2
a
c
t
i
v
i
t
y
(
f
o
l
d
o
f
c
o
n
t
r
o
l
)
[
3
H
]
a
r
a
c
h
i
d
o
n
i
c
a
c
i
d
(
d
p
m
/
a
s
s
a
y
)
cPLA2
(a)
0
100
200
300
400
0
0.3
0.6
0.9
1.2
1.5
AA
C
o
n
t
r
o
l
E
t
(
3
%
)
G
h
+
E
t
S
C
+
G
h
+
E
t
N
S
+
G
h
+
E
t
A
s
+
G
h
+
E
t
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
∗
c
P
L
A
2
a
c
t
i
v
i
t
y
(
f
o
l
d
o
f
c
o
n
t
r
o
l
)
I
n
+
G
h
+
E
t
cPLA2
[
3
H
]
a
r
a
c
h
i
d
o
n
i
c
a
c
i
d
(
d
p
m
/
a
s
s
a
y
)
(b)
Figure 4: Eﬀect of nitric oxide synthase (a) and cyclooxygenase
(b) inhibitors on the ghrelin (Gh)-induced changes in the release
of arachidonic acid and cPLA2 activity in sublingual salivary gland
acinar cells in the presence of ethanol (Et). The cells, preincubated
with 400μM L-NAME (LN), 30μM 1400W (14W), 20μM PP2 and
30μM PD98059 (PD) or 2μM indomethacin (In), 15μM SC-560
(SC), 20μM NS-398 (NS) and 300μM ascorbate, were treated with
Gh at 0.7μg/ml and incubated for 2h in the presence of 3% Et.
Values represent the means ± SD of ﬁve experiments.
∗P <. 05
compared with that of control.
∗∗P <. 05 compared with that of
Et alone.
∗∗∗P <. 05 compared with that of Gh + Et.
blockage of the ghrelin-induced S-nitrosylation, but had no
eﬀect on cPLA2 phosphorylation, whereas ERK1/2 inhibitor,
PD98059, caused the blockage in cPLA2 protein phospho-
rylation as well as S-nitrosylation. These data demonstrate
that the activation of cPLA2 in sublingual salivary gland
acinar cells by ghrelin involves both the phosphorylation
and S-nitrosylation events, and that the enzyme protein
phosphorylation is a prerequisite for its S-nitrosylation.6 Advances in Pharmacological Sciences
Et
Gh
+ ++ +
+
+
+
+ +
LN
PD
S-nitro cPLA2
p-cPLA2
cPLA2
−
−
−
−
−
−
−
Figure 5: Eﬀect of cNOS inhibitor, L-NAME (LN), and ERK1/2
inhibitor, PD98059 (PD), on ghrelin (Gh)-induced cPLA2 S-
nitrosylation in sublingual salivary gland acinar cells exposed to
ethanol(Et).ThecellsweretreatedwithGh(0.7μg/ml)o rL -N AME
(400μM) + Gh or PD98059 (30μM)+Gh and incubated for 2h in
the presence of Et. A portion of the cell lysate was processed by
biotin switch procedure for protein S-nitrosylation and, along with
the reminder of the lysates, subjected to SDS-PAGE, transferred to
nitrocellulose and probed with phosphorylation speciﬁc cPLA2 (p-
cPLA2) antibody, and reprobed with antitotal cPLA2 antibody. The
immunoblots shown are representative of three experiments.
4. Discussion
Investigations into the nature of factors involved in the
maintenance of mucosal integrity along the alimentary tract,
including that of oral cavity, have brought to the forefront
the role of ghrelin in processes of mucosal defense and
repair [29–33]. This 28-amino acid hormone, produced
predominantly in the stomach, but also identiﬁed in oral
mucosa and the acinar cells of salivary glands [29, 33],
has emerged as an important regulator of the cross-talk
between NOS and COX enzyme systems, the products of
which (NO and PGE2) play direct cytoprotective role in
maintaining the soft oral tissue integrity. Moreover, there
are reports indicating that NO and PGE2 are involved in
ghrelin-induced protection of gastric mucosa against injury
by ethanol [31, 32, 34].
As the diminished secretion of saliva and oral mucosal
inﬂammatory changes are well-recognized consequences of
alcohol abuse on the health of oral cavity [2–4], in the
study presented herein we examined the mechanism of
ghrelin protection of salivary gland secretory cells against
ethanol cytotoxicity. Using the acinar cells of rat sublingual
salivary gland exposed to ethanol at the concentration range
that impairs mucosal cell capacity for mucin synthesis and
prostaglandin generation [5, 9], we demonstrated that the
protective eﬀect of ghrelin was associated with the increase
in NO and PGE2 production, and marked up-regulation
in cPLA2 activity and AA release. Moreover, a signiﬁcant
loss in the countering eﬀect of ghrelin on the ethanol-
induced toxicity was attained with cNOS inhibitor, L-NAME
as well as indomethacin and a speciﬁc COX-1 inhibitor, SC-
560, while speciﬁc COX-2 inhibitor, NS-398, and a selective
iNOS inhibitor, 1400W had no eﬀect. These results, are thus
in keeping with the literature data demonstrating that the
detrimental eﬀects of ethanol on gastric mucosal integrity
are associated with the impairment in NO synthesis and
PGE2 generation controlled by cNOS and COX-1 enzyme
systems [31, 33]. Moreover, our ﬁndings on the inhibition
of ghrelin-induced acinar cell capacity for NO production as
well as PGE2 generation by L-NAME, and only that of PGE2
by indomethacin and COX-1 inhibitor, SC-560, suggest that
cNOS-derived NO participates in the regulation of PGE2
production in response to ghrelin.
Since the initial and rate limiting event in prostaglandin
production is the release of AA from membrane phos-
pholipids by highly selective cPLA2 [22–24], we further
assessed the inﬂuence of ghrelin on the processes of cPLA2
activation. Employing the acinar cell labeled with AA, we
demonstrated that ethanol cytotoxicity was manifested in
a diminished AA release, while preincubation with ghrelin
led to cPLA2 activation as evidenced by the increase in
AA release. This stimulatory eﬀect of ghrelin was subject
to suppression by cNOS inhibitor, L-NAME but not the
iNOS inhibitor, 1400W or the inhibitors of COX-1 and
COX-2 enzymes. Moreover, we found that up-regulation in
AA release and cPLA2 activity evoked by ghrelin was also
suppressed by the inhibitor of ERK1/2, PD98059. Hence, the
ghrelin-induced acinar cell cPLA2 activation for the increase
in PGE2 production to counter ethanol cytotoxicity requires
cNOS and MAPK/ERK participation. This interpretation of
our results is supported by the literature data indicating
that activation of cPLA2 for rapid increase in AA release
and eicosanoid generation occurs through posttranslational
MAPK/ERK-dependent enzyme protein phosphorylation on
the critical Ser505 residue that plays a crucial role in Ca2+-
dependenttranslocationofcPLA2 fromcytosoltomembrane
to gain access to phospholipid substrates [14, 25–27].
Interestingly,recentevidenceindicatesthatinadditionto
posttranslational activation by phosphorylation, the increase
in prostaglandin formation may also result from NO-
induced enzyme protein S-nitrosylation [17, 20, 28]. Indeed,
the posttranslational modiﬁcation of the protein through S-
nitrosylationatthecriticalcysteine526 residuehasbeenlinked
to the NO-induced enhancement in catalytic activity of
COX-2[17],andcPLA2 activationthroughS-nitrosylationat
cysteine152 was reported to be responsible for up-regulation
in AA release in human epithelial cells [28]. Therefore,
to assess the role of cNOS-derived NO in the ghrelin-
induced cPLA2 activation for the protection of salivary
gland acinar cells against cytotoxic eﬀect of ethanol, we
examined the cPLA2 activity, and its protein S-nitrosylation
and phosphorylation. We found that, In keeping with well
known susceptibility of S-nitrosylated proteins to reduction
by ascorbic acid [17, 37, 38], the ghrelin-induced regulation
in cPLA2 activity and AA release was liable to suppression
by ascorbate. Preincubation with cNOS inhibitor, L-NAME
led to the blockage in ghrelin-induced cPLA2 protein S-
nitrosylation but had no eﬀect on its phosphorylation,
whereas ERK1/2 inhibitor, PD98059 caused the blockage in
boththecPLA2 proteinphosphorylationandS-nitrosylation.
Thus,theactivationofcPLA2 intheacinarcellsbyghrelinfor
the increase in AA release and PGE2 synthesis involves theAdvances in Pharmacological Sciences 7
enzyme processing through the events of phosphorylation
and S-nitrosylation. It is also apparent that the cPLA2
phosphorylation is a prerequisite for its S-nitrosylation.
Whileourresultsonthemechanismofghrelinprotection
of salivary gland acinar cells against ethanol cytotoxicity are
obtained employing the in vitro system and pharmacological
concentrations of the peptide, it should be noted that
protective eﬀects of the peripherally administered ghrelin
against acute gastric mucosal injury induced in rat stomach
by ethanol also required considerably higher concentrations
of the peptide than that of central ghrelin [30, 32, 34].
This is consistent with the advocated role of hypothalamic
neuromodulatory pathways in ghrelin action [39].
In summary, our ﬁndings demonstrate that ghrelin
protection of salivary gland acinar cells against ethanol
cytotoxicity involves cNOS-derived NO induction of cPLA2
activation through S-nitrosylation for the increase in PGE2
generation.
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